Gemelli Biotech Corp. — Form D/A

Gemelli Biotech Corp. of Raleigh, NC, a company, filed a Form D amendment with the SEC on 2024-12-02. The offering totals $23.9M, of which $21.2M was reported sold. Industry: Biotechnology.

Offering

Filed: 2024-12-02
Form: D/A
Accession: 0001780605-24-000001
Industry: Biotechnology
Exemptions: 06b
Total offering: $23.9M
Amount sold: $21.2M
Remaining: $2.7M
Investors: 128
Date of first sale: 2021-12-07
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-448519

Issuer

Name: Gemelli Biotech Corp.
CIK: 0001780605
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2018
Address: 2009 Fairview Rd. #6099, Raleigh, NC, 27628
Phone: (919) 451-0533

Officers, directors & promoters (8)

Name	Role	Location
Ritish A Agarwal	Director	Raleigh, NC
James Laur	Director	Raleigh, NC
Oded A Levy	Director	Raleigh, NC
Matthew Mitcho	Director	Raleigh, NC
John A Neczesny	Director	Raleigh, NC
Matthew Mitcho	Executive Officer	Raleigh, NC
Mark Pimentel	Director	Raleigh, NC
Mark Pimentel	Executive Officer	Raleigh, NC

Other filings by this issuer (4)

Filed	Form	Offering	Sold
2022-06-08	D	$20.0M	$18.9M
2021-03-29	D/A	$5.5M	$5.5M
2021-03-26	D	$5.0M	$5.0M
2019-06-28	D	$3.0M	$1.9M

More